Rachel McMinn Recent News
UPDATE: Bank of America Downgrades Achillion Pharmaceuticals Following Extremely Negative Pipeline Update
UPDATE: Bank of America Downgrades ViroPharma on Valuation
UPDATE: Bank of America Raises PT on Incyte on Compelling New Data
UPDATE: Bank of America Downgrades Merrimack Pharmaceuticals Following Series of Disappointing Updates
UPDATE: Bank of America Downgrades ViroPharma on 2Q Results
UPDATE: Bank of America Initiates bluebird bio at Buy on Transformational Potential
Bank of America Reiterates Underperform Rating on Idenix Pharmaceuticals Following FDA Suspension Announcement